Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Watson Pharma Pvt Ltd history
Watson Pharma Pvt Ltd company history timeline
Chao began developing a generic substitute for the original patented product in 1986, and it eventually won the FDA's blessing.
Despite heavy investments in ongoing research and development, Watson managed to boost profits to $1.26 million in 1989, from sales of nearly $21 million.
By late 1993, in fact, Watson had the exclusive right to produce 17 generic products, and was also making about 40 drugs for other companies.
In 1993, moreover, sales nearly doubled to $67.6 million, a hefty $12.2 million of which was netted as income.
Watson's revenues rose to $87 million in 1994 as it introduced new drugs to market.
After the merger was complete, Watson's product line had grown to include more than 80 different drugs (variations of 30 major pharmaceutical products). Sales for 1995 increased to $153 million, reflecting the merger as well as revenue growth related to new and established products.
In 1996 it was selling more than 80 different products throughout the United States and parts of the world.
In 1998, it acquired the rights to three additional products.
During 2000, the firm doubled in size with its purchase of competitor Schein Pharmaceutical Inc., a manufacturer of nearly 100 generic products.
In 2003, Watson was operating as the fifth largest pharmaceutical company in the United States, based on prescriptions dispensed, and the third largest generic drug company in the nation.
Rate how well Watson Pharma Pvt Ltd lives up to its initial vision.
Watson Pharma Pvt Ltd jobs
Do you work at Watson Pharma Pvt Ltd?
Does Watson Pharma Pvt Ltd communicate its history to new hires?
Watson Pharma Pvt Ltd competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Hi-Tech Pharmacal | 1982 | $232.4M | 200 | - |
| Amneal Pharmaceuticals | 2002 | $2.8B | 6,500 | 92 |
| Merck | 1891 | $64.2B | 74,000 | 1,454 |
| RedHill Biopharma | 2009 | $64.4M | 100 | - |
| SOHM | - | $3.5M | 42 | - |
| Manhattan Drug | 1979 | $43.7M | 100 | - |
| Sesen Bio | 2010 | $19.6M | 35 | - |
| Mylan | 1961 | $11.5B | 35,000 | 3 |
| Par Pharmaceutical Inc | 2003 | $260.0M | 400 | - |
| Sun Pharmaceutical Industries Inc. | 1984 | $4.2B | 32,000 | 135 |
Watson Pharma Pvt Ltd history FAQs
Zippia gives an in-depth look into the details of Watson Pharma Pvt Ltd, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Watson Pharma Pvt Ltd. The employee data is based on information from people who have self-reported their past or current employments at Watson Pharma Pvt Ltd. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Watson Pharma Pvt Ltd. The data presented on this page does not represent the view of Watson Pharma Pvt Ltd and its employees or that of Zippia.
Watson Pharma Pvt Ltd may also be known as or be related to ACTAVIS INC., Actavis, Actavis LLC, Actavis Pharma, Inc., Actavis, Inc. and Watson Pharma Pvt Ltd.